OR WAIT null SECS
Biosimilars, advances in treatment for rheumatoid and juvenile arthritis, numerous new guidelines and drug approvals. Review the past year's progress in rheumatology, as compiled by our Editorial Board.
Compiled based on choices from the RheumatologyNetwork Editorial Board.
Advances in RA Treatment
New FDA Drug Approvals
Cause for Caution on Meniscal Tear
New Alternative for ANCA-Associated Vasculitis